[1]thx to futundbiedl on flickr creative commons
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us and we’ll share it with others. That’s right. Send us your changes and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going, especially with all the ongoing layoffs. Despite the downsizing, there is movement. Here are some of the latest comings and goings. Recognize anyone?
And here is our regular feature in which we highlight a different person each week. This time around, we note that Telesta Therapeutics hired Brian Groch as chief commercial officer. Most recently, he was vice president of market access at Horizon Pharma and, before that, he worked at Dendreon, where he built the commercial organization that launched Provenge.
CSL hired David Lamont as chief financial officer;
Rodin Therapeutics hired Adam Rosenberg as chief executive officer;
Aerpio Therapeutics hired Steve Pakola as chief medical officer;
Scynexis hired Rajeshwar Motheram as vice president, pharmaceutical development;
Immusan hired Michael Cooreman as chief medical officer;
Immusan hired Anita Treohan as director of clinical operations;
Lycera hired Alex Howarth as chief financial officer;
Luc Therapeutics, formerly Mnemosyne Pharmaceuticals, hired Tim Piser as chief scientific officer;
Arena Pharmaceuticals named Harry Hisxon as interim ceo;
Ritter Pharmaceuticals hired AnnKatrin Petersen-Jappelli as chief medical officer;
Novan Therapeutics hired Richard Petersen as chief financial officer;
Novan Therapeutics hired Brian Johnson as chief commercial officer;
Metamark Genetics hired Peter Maimonis as sr vp and chief science officer;
Tracon Pharmaceuticals hired Ronald Shazer as chief medical officer;
Osmotica Pharmaceuticals hired Samer Kaba as vp and head of global clinical development and medical affairs;